文献库，生知库 | 链接生命科学的每一步

日期影响因子

Holding vs Continuing GLP-1/GIP Agonists Before Upper Endoscopy: The OCULUS Randomized Clinical Trial

上消化道内镜检查前停用与继续使用GLP-1/GIP激动剂的比较：OCULUS随机临床试验

期刊:Jama Internal Medicine

影响因子:23.3

doi:10.1001/jamainternmed.2026.0027

Ahmad, Akram I; Garg, Samita; Jacobs, Jeffrey; Ansari, Zaid; Al-Din, Tasneem Jamal; Almomani, Ashraf; Valencia, Sara; Vargo, John; Chatterjee, Arjun; Siddiki, Hassan; Hong, Liang; Nicolas, Michael A; Miller, Alaina; Shah, Tilak

发表日期：2026

文献求助收藏

The other face of GWAS: Editorial on "Genome-wide interaction study with body mass index identifies CYP7A1 and GIPR as genetic modulators of metabolic dysfunction-associated steatotic liver disease"

GWAS的另一面：社论“全基因组相互作用研究与体重指数相结合，发现CYP7A1和GIPR是代谢功能障碍相关脂肪肝疾病的遗传调节因子”

期刊:Clinical and Molecular Hepatology

影响因子:16.9

doi:10.3350/cmh.2025.0677

Sim, Hyungtai; Choi, Murim

发表日期：2026

文献求助收藏

Letter to the editor on "Genome-wide interaction study with BMI identifies CYP7A1 and GIPR as genetic modulators of MASLD"

致编辑的信，主题为“全基因组与BMI的相互作用研究发现CYP7A1和GIPR是MASLD的遗传调节因子”

期刊:Clinical and Molecular Hepatology

影响因子:16.9

doi:10.3350/cmh.2025.0656

发表日期：2026

文献求助收藏

Editorial on "Genome-wide interaction study with body mass index identifies CYP7A1 and GIPR as genetic modulators of metabolic dysfunction-associated steatotic liver disease"

关于“全基因组相互作用研究与体重指数发现CYP7A1和GIPR是代谢功能障碍相关脂肪肝疾病的遗传调节因子”的社论

期刊:Clinical and Molecular Hepatology

影响因子:16.9

doi:10.3350/cmh.2025.0923

Kozlitina, Julia

发表日期：2026

文献求助收藏

Novel evidence for tirzepatide, a dual GLP-1/GIP receptor agonist, to reduce the motivation for cocaine in rodents

双重 GLP-1/GIP 受体激动剂 tirzepatide 可降低啮齿动物对可卡因的渴求的新证据

期刊:EBioMedicine

影响因子:10.8

doi:10.1016/j.ebiom.2026.106257

Knackstedt, Lori A

发表日期：2026

文献求助收藏

Dysfunctional Lipid-Induced Secretion of Glucagon-Like Peptide-2(GLP-2), but Not of Incretins Glucagon-Like Peptide-1(GLP-1)/Glucose-Dependent Insulinotropic Polypeptide(GIP), Promotes Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Onset and Progression Through Gut Barrier Disruption and Endotoxemia

脂质诱导的胰高血糖素样肽-2 (GLP-2) 分泌功能障碍，而非肠促胰岛素样肽-1 (GLP-1)/葡萄糖依赖性胰岛素促泌多肽 (GIP) 分泌功能障碍，通过肠道屏障破坏和内毒素血症促进代谢功能障碍相关性脂肪肝病 (MASLD) 的发生和发展。

影响因子:10.7

doi:10.1002/mco2.70323

Musso, Giovanni; Pinach, Silvia; Mella, Alberto; De Michieli, Franco; Calabrese, Anna; Trifiro, Deborah; Petrangolini, Giovanna; Cassader, Maurizio; Mariano, Filippo; Gambino, Roberto

免疫/内分泌

发表日期：2026

文献求助收藏

The promoting roles of GLP1R and GIPR in stemness maintenance and multiple lineage-specific differentiation of PDLSCs.

GLP1R 和 GIPR 在 PDLSC 干性维持和多谱系特异性分化中的促进作用。

期刊:Cellular & Molecular Biology Letters

影响因子:10.2

doi:10.1186/s11658-026-00867-2

发表日期：2026

文献求助收藏

GIPC1 Restrains the Progression and Chemoresistance of Colorectal Cancer by Regulating TTC7B/mTOR/NF-ÎºB Axis.

GIPC1 通过调节 TTC7B/mTOR/NF-κB 轴抑制结直肠癌的进展和化疗耐药性。

期刊:International Journal of Biological Sciences

影响因子:10

doi:10.7150/ijbs.119064

Gan Dongxue, Yang Cheng, Shen Xiangjing, Shi Jingjie, Wang Ronglin, Zhu Liaoliao, Li Hong, Luo Jing, Zhao Ting, Li Junqiang, Song Yang, Su Haichuan

发表日期：2026

文献求助收藏

GIPC2 regulation of the PKM2/SREBP1 signaling axis controls adipogenic differentiation of mesenchymal stem cells.

GIPC2 调控 PKM2/SREBP1 信号轴控制间充质干细胞的脂肪生成分化。

期刊:Cell Death & Disease

影响因子:9.6

doi:10.1038/s41419-025-08088-9

Wang Jiayi, Xin Chengqi, Sun Zhaokai, Zhao Mengke, Zan Yaoyao, Lv Zhongyue, Zhu Shuaiyu, Liu Jing, Wang Liang

发育与干细胞

发表日期：2026

文献求助收藏

Dietary intake patterns and nutritional adequacy among adults with overweight or obesity treated with GLP-1 or dual GIP/GLP-1 receptor agonists- preliminary study

接受 GLP-1 或双重 GIP/GLP-1 受体激动剂治疗的超重或肥胖成年人的膳食摄入模式和营养充足性——初步研究

期刊:Journal of Translational Medicine

影响因子:7.5

doi:10.1186/s12967-026-07702-4

Korus, Sebastian; Cembrowska-Lech, Danuta; Kłoda, Karolina; Stachowska, Ewa

发表日期：2026

文献求助收藏